Work

A phase 2 study of orally administered PLX3397 in patients with recurrent glioblastoma.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.2023

Authors: Nicholas A. Butowski, Howard Colman, John Frederick De Groot, Antonio Marcilio Padula Omuro, Lakshmi Nayak, Timothy F. Cloughesy, Adhirai Marimuthu, Arie Perry, Joanna J Phillips, Brian West, Michael Prados, Keith B. Nolop, Henry H Hsu, Keith L. Ligon

Institutions: University of California, San Francisco, University of Utah, Huntsman Cancer Institute, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, University of California, Los Angeles, Plexxikon (United States), Brigham and Women's Hospital, Boston Children's Hospital

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587697103

Cites:

Cited by: 19

Related to: 10